AbCellera
Biotechnology ResearchCanada501-1000 Employees
AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
AbCellera uses 8 technology products and services including Leadfeeder, PostgreSQL, DocuSign, and more. Explore AbCellera's tech stack below.
| AbCellera Email Formats | Percentage |
| First.Last@abcellera.com | 97% |
| First.Middle@abcellera.com | 2% |
| First.MiddleLast@abcellera.com | 1% |
Biotechnology ResearchCanada501-1000 Employees
AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
AbCellera has raised a total of $1.1B of funding over 6 rounds. Their latest funding round was raised on Dec 01, 2020 in the amount of $555Mas a IPO.
AbCellera's revenue is estimated to be in the range of $25M$50M
AbCellera has raised a total of $1.1B of funding over 6 rounds. Their latest funding round was raised on Dec 01, 2020 in the amount of $555Mas a IPO.
AbCellera's revenue is estimated to be in the range of $25M$50M